Archive
DRY TOILET 2009 Conference proceedings and presentations
The proceedings from the DRY TOILET 2009 conference held by Global Dry Toilet Association of Finland are available They are a great resource and available at http://huussi.net/tapahtumat/DT2009/full.html
The summary is also avaliable in – suomi (Finish) and Russian as a pdf
The Suomi version of the home page is http://www.huussi.net/
| Session | Presentations
& |
|
| 1 PROMOTING ECOLOGICAL SANITATION IN ORDER TO ACHIEVE MDG’S |
||
|
India, Namibia, Finland, Tajikistan, Nepal, Uganda |
|
| 2 HEALTH AND SAFETY ASPECTS RELATED TO DRY SANITATION |
||
|
Philippines, India, Argentina, Belarus, Nigeria | |
| 3 IMPLEMENTING ECOLOGICAL SANITATION IN EMERGENCIES |
||
|
Pakistan, Bangladesh, Chad |
|
| 4a PROSPECTS AND CHALLENGES IN RE-USE OF EXCRETA | ||
|
Mexico, Benin, Ethiopia |
|
| 4b PROSPECTS AND CHALLENGES IN RE-USE OF EXCRETA continues |
||
|
Finland, Kenya, Ghana, Burkina Faso, Sri Lanka |
|
| 5 CHALLENGES IN IMPLEMENTING ECOLOGICAL SANITATION |
||
|
Mexico, Columbia, Zambia |
|
| 6 GENDER ASPECTS RELATED TO DRY SANITATION |
||
|
Nepal, Uganda, Bangladesh |
|
| 7a TECHNICAL DEVELOPMENT OF DRY TOILETS |
||
|
Kenya and Bangladesh and others |
|
| 7b TECHICAL DEVELOPMENT OF DRY TOILETS continues |
||
|
Finland, Ethiopia, Inner Mongolia, China |
|
| 8 CAPACITY BUILDING |
||
|
Sweden, Kyrgyzstan, Tanzania,Kenya, India |
|
| Side event SUSTAINABLE SANITATION FOR TOURISM AND RECREATION |
||
|
Scotland, Republic of Karelia, Russia, Kazakhstan, Finland |
|
EcoSan video focusing on Urine as Fertilizer
Here is great video showing how the EcoSan toilet works, stressing:
1 You don’t need water to us an EcoSan toilet, saving a precious resource
2 There is a huge benefit to use urine as a fertilizer
The video the workings of toilet itself. What I find wonderful is that this video explains & shows the full sequence of steps taken to after urination to get the urine onto the the field as fertilizer. This is followed by a wonderful comparison of crop yields comparing side by side fields, on fertilized with urine the other fertilized with commercial fertilizer. The fields fertilized with urine did better than the commercial fertilizers and at NO COST!!!! The video is in English and the location is Ethiopia. Several local experts are use to explain particular points.
Title Urine Diversion Toilets: advantages and use agriculture
a brief Ecosan Documentary by Andreas Wilkin c 2008
produced for the ROSA project
contact Franziska Meinzinger f.meinzinger @ tu-harburg.de
Technische Universitat Hamburg-Harburg TUHH
(Hamburg University of Technology)
WASHLink Notes: addition resources:
other related YouTube videos (using following search terms)
| ecosan urine | ecosan construction | ecosan watsan |
| ecosan design materials | ecosan fertilizer | ecosan toilet |
WHO:
Google Scholar search
JAMA addresses effectiveness of Azithromycin in treating Trachoma
source JAMA Vol. 302 No. 9, September 2, 2009 Abstract
http://jama.ama-assn.org/cgi/content/abstract/302/9/962
From article titled:
“Effect of Mass Distribution of Azithromycin for Trachoma Control on Overall Mortality in Ethiopian Children”
Context Mass oral azithromycin distribution to affected communities is a cornerstone of the World Health Organization’s trachoma elimination program. Antibiotics are provided to target the ocular strains of chlamydia that cause trachoma, but may also be efficacious against respiratory disease, diarrhea, and malaria—frequent causes of childhood mortality in trachoma-endemic areas.
Interventions A single dose of oral azithromycin (adults, 1 g; children, 20 mg/kg) was administered for treatment of ocular Chlamydia trachomatis infection. Antibiotic coverage levels for children aged 1 to 9 years exceeded 80% at all visits.
Results The odds ratio for childhood mortality in the intervention communities was 0.51 (95% confidence interval, 0.29-0.90; P = .02; clustered logistic regression) compared with the control group.
In the treated communities, for children aged 1 to 9 years
- the estimated overall mortality rate during this period for in the untreated group was 8.3 per 1000 person-years (95% confidence interval, 5.3-13.1),
- while among the treated communities, the estimated overall mortality rate was 4.1 per 1000 person-years (95% confidence interval, 3.0-5.7)
Travis C. Porco, PhD, MPH; Teshome Gebre, MBA; Berhan Ayele, MSc; Jenafir House, MPH; Jeremy Keenan, MD; Zhaoxia Zhou, BS; Kevin Cyrus Hong, BS; Nicole Stoller, MPH; Kathryn J. Ray, MA; Paul Emerson, PhD; Bruce D. Gaynor, MD; Thomas M. Lietman, MD
source: abstract Vol. 302 No. 9, September 2, 2009 Journal of the American Medical Association JAMA. 2009;302(9):962-968. : http://jama.ama-assn.org/cgi/content/abstract/302/9/962
A Brief Background on Trachoma:
“Trachoma, a disease caused by bacteria called Chlamydia trachomatis, affects more than 80 million individuals worldwide, and 8 million persons are blind because of this infection. Inflammation of the conjunctiva (lining of the eye surface) causes irritation and scarring, leading to blindness if trachoma is not treated. Trachoma is a serious public health problem in developing countries. Better sanitation and improved clean water supplies are ways to decrease the prevalence of trachoma and reduce trachoma-related blindness. Trachoma occurs in children as well as adults in all parts of the world. Women are much more likely than men to develop trachoma or become blind from trachoma. In the United States, blindness due to trachoma has been eliminated because of widespread prevention and treatment efforts. Since trachoma is a contagious disease, it can occur in family groups or in persons who live in close quarters. The bacteria are spread by secretions from the eye or the nose and pass from person to person. Flies can also pass on the bacteria, especially in areas that have poor sanitation. The September 2, 2009, issue of JAMA includes an article about the effects of mass distribution of an antibiotic for treatment and prevention of trachoma.”
source and for more details ( SIGNS AND SYMPTOMS, TREATMENT AND PREVENTION, and addition links) see the following JAMA Patient Page http://jama.ama-assn.org/cgi/content/full/302/9/1022?home

